Lv3
310 积分 2025-07-30 加入
Acute lymphoblastic leukaemia
18小时前
已完结
CAR T-cells for acute leukemias in children: current status, challenges, and future directions
19天前
已完结
Acute lymphoblastic leukaemia
26天前
已完结
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
26天前
已完结
Acute lymphoblastic leukaemia
2个月前
已完结
Chimeric antigen receptor T cells as adjuvant therapy for unresectable adenocarcinoma
2个月前
已完结
Re: Chimeric Antigen Receptor T Cells as Adjuvant Therapy for Unresectable Adenocarcinoma
2个月前
已完结
FDA Approval Summary: Lisocabtagene Maraleucel for Second-Line Treatment of Large B-Cell Lymphoma
5个月前
已完结
Lisocabtagene maraleucel as second-line therapy in adults with relapsed or refractory large B-cell lymphoma who were not intended for haematopoietic stem cell transplantation (PILOT): an open-label, phase 2 study
5个月前
已完结
Lisocabtagene maraleucel as second-line therapy for large B-cell lymphoma: primary analysis of the phase 3 TRANSFORM study
5个月前
已完结
皖公网安备34019202002308
